KGK Science Enters into Research Contract With Nova Mentis for Phase II A Trial
17 Nov 2022 //
BUSINESSWIRE
Nova Mentis Study Confirms Oral Microdose Psilocybin Treatment of Autism
16 Feb 2022 //
PRNEWSWIRE
Nova Mentis Files Genetic Neuroinflammatory Disease Patent
09 Nov 2021 //
PRNEWSWIRE
Nova Mentis Applies to US FDA for Psilocybin Orphan Drug Designation
14 Sep 2021 //
YAHOO
Nova Mentis Expands Psilocybin Research Program Targets Obesity and Diabetes
07 Sep 2021 //
PRNEWSWIRE
Nova Mentis Files Fragile X Orphan Drug Designation with EMA
12 Aug 2021 //
NEWSWIRE